Skip to main content
ADUS $122.50 +1.18%
ADUS logo
ADUS · Addus HomeCare Corp
Track ADUS — free
Market Cap
$2.28B
Shares
18.63M
Volume · Nov 20 254.4K Avg daily vol (3M) 221.03K
All webcasts

Conference · 2026-11-17

Addus HomeCare Corp (ADUS) November 17, 2026 Conference Transcript

Concluded Nov 17, 2026 Audio replay
Nov 17, 2026 35:32 34 turns
Period
2026-11-17
Runtime
35:32
Sources
2 artifacts

Transcript & audio

35:32 Audio
Raj Kumar Analyst — Stevens

Looks like we're at the top of the hour so we can get started. Welcome, everyone, to day one of the Stevens 2026 Annual Investment Conference live and in person from Nashville. I'm Raj Kumar, Healthcare Services Analyst at Stevens. To start off our Healthcare Services Fireside Chats, we have Addis Home Care, a leading provider of home-based care and support services focusing on providing personal care, hospice, and home health services. Joining us here today from Addis are Dirk Allison, Chairman and CEO, and Brian Pock, EVP and CFO. I want to thank you both for joining us here at our conference today, and I think we'll just jump right into Q&A if that sounds good. Awesome. Maybe just to kick off the conversation, 2026 has been a good year across all three lines of businesses, but as we think about maybe going through a year in review, maybe walk us through how 2026 has played out relative to your internal expectations.

Dirk Allison Chairman

Sure. You know, we think 26 has been a good year for us, and like you mentioned, all three levels of care. It started out with a little bit of a cloud over the industry. I think with OB3 out there, people not understanding exactly how the Medicaid cuts were going to affect our business. We internally felt like, you know, if you look at the work requirements, you look at the taxes that they were going to change, we didn't feel like it would be a direct impact on our company. In fact, in the case of work requirements, we wondered would it be somewhat of a tailwind on hiring. So that was something I think the industry had to deal with. I think what we've seen is we've gone through the year. Our performance financially has been pretty strong. We got our home health headed back in the right direction. PCS has done well. We've had hourly growth. And I think what's really reflected itself. We haven't seen big negative impacts as it relates to OB3. You know, we had one state out in the West, Montana, that's actually already put in work requirements. So it was a little bit of a test for us to see how would it affect the company. And really, what we would say is it's had no effect. We haven't seen any decrease on the number of patients we've been able to bring into the system. The state has been able to handle the work requirements appropriately. On the other side, maybe it's still early, but 90 to 120 days in, we haven't seen an influx of people looking to go to work either. So I would say 26 has been a good year. We started the year believing there were going to be... Acquisition opportunities out there, especially in the PCS world this year. We were able to announce during the year, obviously, the Accent Care transaction, which we should close in the first quarter. So, again, another opportunity that grows our business by about $280 million a year in revenue, which is another important aspect. So, pretty excited. We look forward to 27 also. So we think it's going to be another good year, not only from the standpoint of continued incremental improvements, as we've seen, but also we think there'll be some acquisition opportunities we can take advantage of.

Raj Kumar Analyst — Stevens

Got it. Yeah, I mean, maybe kind of table setting broadly for 2027. I guess kind of one of some of the puts and takes to keep in mind. I know you've talked about clinical acquisitions, but CMS extended the moratorium, although there's some nuances there that provide some relief for existing licenses. Maybe just kind of talk about 2027 in that context and kind of how you see the M&A landscape in terms of you still being kind of able to execute on your kind of clinical acquisition targets or kind of what's in the pipeline as we kind of think about expansion in that business.

Dirk Allison Chairman

Sure. You know, I think one of the exciting things is we've already got one of the big ones done. We should close Accent Care. February is what we're hoping for. We've already passed antitrust, so we're just waiting on the additional regulatory approvals we need. We're in the process right now of meeting with their team. We've been very open developing the transition plan, and so that really allows us, hopefully, now to start looking at that next big deal out there. And so we're aware of two or three things that should be coming up in 27. One of the things that we've done as a company, Brian's done a very good job as our chief financial officer, is keeping our balance sheet clean. When we close on Accent Care, we will still only be levered about one times, so still have debt capacity to do other larger transactions. And so, well, we will. We've already started talking to some folks, but as the processes get more official, we see opportunities to do some things. There's one or two PCS transactions we know are going to be out there, but as we talked about on the call, one of the things we'd like to do also is bring some more clinical services to the company. You know, if you go back three or four years ago, we ran 25% or so of the business was clinical services with Gentiva closing and then followed by accident care. We're going to be down to about 18% on the clinical side. We'd like to get that up 25%, 30%. So we'll be looking at, we'll continue to look at personal care also. We're not going to, that's our main business, but we believe supplementing that with clinical services in 27 is a real opportunity we're looking forward to.

Raj Kumar Analyst — Stevens

Got it. And as we kind of think about the midterms, I'm going to be asking this of all of our companies here, but how do you kind of see the midterms in terms of the benefits to your business kind of broadly? And then maybe are you seeing any potential concerns from a policy perspective as we kind of see what the kind of Dems have kind of been wanting to do from a provider standpoint?

Dirk Allison Chairman

Yeah, you know, our biggest challenge over the last A couple years has been the federal government coming out like with OB-3 and taking Medicaid money away. It appears with the Democratic majority in the House and the Senate, that probably has gone away. They're talking about trying to do things such as eliminate or at least defer work requirements. We saw that come out this week where we got a six-month deferral. So I think from a standpoint of the regulatory environment, we're in a little bit better position today than we might have been before. Democratic leadership has tended to put more dollars into Medicaid and the lower income benefits that we operate in for the majority of our business. So we're pretty excited about that. You know, in most of our states, New Mexico, our three large states, New Mexico and Illinois, already had Democratic. The leadership, not much should change there with the exception of we should hopefully see continued rate increases. Maybe Illinois was skipped a year. Well, hopefully we'll be back to getting that rate increase next year. The interesting one's Texas. You know, we went from a red state from a state standpoint to a blue state in one election for the first time in 30 years. And The Republican leadership before had shown the last two bisennial sessions that they've given us rate increases. We were already in the process with our lobbyists and our state association of talking to them about the next session starting in January of 27 about getting a rate increase. So now it's going to be interesting to see how does having new Democratic leadership affect that. We would believe with Texas's rainy day fund, the funds they have, that maybe we can get some more dollars put into the elderly population, elderly and disabled population. But we'll see. But all things being told, we think it's probably a little easier environment after the recent elections than maybe we faced before.

Raj Kumar Analyst — Stevens

Got it, got it. When I kind of think about Addis, there's this value proposition of having these three levels of care, and you don't really see that, at least amongst other public companies that have personal care, home health and hospice, at least to the scale that you guys have built up. I guess kind of what's the kind of clearest evidence, you know, kind of of having that three service model in terms of the benefit that you guys see across maybe cross referrals, you know, clearly you've highlighted the bridge program with home health and hospice, but as I kind of think about longer term, you know, value to the payers in terms of value based care, you know, what's something that, you know, where you stand out more when you even kind of do point of sale solutions relative to someone that's just a single service operator?

Dirk Allison Chairman

You know, everybody thinks about it differently. I'm talking about the provider. Think of their business. We've always taken the approach that personal care is the one service that is in the elderly home the most. You know, we're in home health. You might be in once a week, once every two weeks, depending on the plan of care. Certainly hospice is a different environment. Um, but if you think of personal care, we're in there anywhere from three to five times a week. We're in there from two hours to four hours. We see this elderly patient. Every day, and we're the first, we should be the first line of defense that sees if there are changes of condition. And if you start thinking in terms of your payers, the payers issue is these are a very high cost member. The elderly population, we are talking 75 years above, they're the ones that tend to go to the emergency room, readmits to the hospital, they're the ones that have difficulty getting to their PCP, to have flu shots, other aspects taken care of, the kind of preventative measures to keep them from the higher cost care. And so what we've been able to work with our payers on is we can use the non-clinical base as a start, supplemented by the clinical services we're able to bring over to top of that to try to help them with value-based care. And we've had a number of programs over the last few years that have proven, especially around two or three areas, readmits to hospitals after surgery. Emergency room visits that can be avoided. You know, there are certain emergency rooms you can, but some you can. And then closing care gaps. Like I said, the flu shots and the other things that might lead to hospitalizations if these patients are not able to access that particular kind of care. We've been able to work with our payers to show them value with that. And so our belief is that all starts with personal care. We're the ones there that see them so often, and then we can move up the ladder to help the payers. And it's proven to be very effective. We have programs going in New Mexico. We have them going to Texas. We have them going in Illinois. So we're pretty excited about that future, and we're continuing to talk to our payers about how we can do more with them along those lines.

Raj Kumar Analyst — Stevens

Got it. And as I kind of think about maybe personal care and home health is like kind of those two conjoined services. And I know you guys used to run or maybe are still running a pilot in New Mexico and Presbyterian around kind of bundling those offerings. I guess what, you know, when we think about, you know, clearly they require scale on both sides as a standalone from, you know, personal care and home health. You have the personal care scale. You know, you're trying to build out the home health scale. As we kind of think about what scale is required on the home health side to be able to wrap around those services together, maybe kind of help us kind of think about, you know, what that path looks like. And as we think about maybe the BRICH program is like a proxy, like you get 25% of your referrals from the home of your own home health business. Like, what would it take to get to something similar where you're also serving the home health benefit of that same patient?

Dirk Allison Chairman

Yeah, you know, one of the things we're doing, we have this huge population base of, what, 65,000 elderly individuals that have various health care needs. And we've been focusing, as you've said, on the bridge program between home health and hospice. And we're up to about 30% now in our own admissions into hospice when we have overlapping home health in that market. What we have found as it relates to the value-based care is, if you start with PCS, you don't necessarily have to have a full-blown home health on top of that just for this value-based care. You can have clinical assets, whether it's RNs, different folks that you can draw on that can work on value-based care. But our long-term approach is this. If we can take this large population of non-clinical care and start using technology... To help them understand and help us understand where it's the payers, whether it's the patients and their families, or whether it's us, when are they getting close to needing other segments of care up the line? That's very important to us. And it's a bridge program that doesn't start with home health, it starts with personal care. To do that, we need technology that's the same all the way across, which leads to the fact that we're in the middle of a process of moving all of our personal care systems over to home care home base. Once that is completed, then we believe we should be able to see a lot of benefits of moving up the level of care with these patients that start from a non-clinical basis.

Raj Kumar Analyst — Stevens

Got it. Got it. Yeah, maybe let's kind of focus on non-personal care. You know, the biggest kind of operating division within that is, you know, kind of heading into 2027, I think you framed, you know, organic growth within the long-term 3% to 5% as we're kind of, Illinois is kind of bypassing the rate for next year. Although, we'll know if it comes back for 2028. But, you know, on the volume side, clearly billable hours growth from the same-store perspective as well has kind of been, you know, in that 2% to 2.5% range that you guys target. Largely driven by just, you know, maximizing the fill rate in the kind of mid-80s. I guess as we kind of think about the fill rate component, I think you guys target maybe an upper 80% fill rate. And what are the functions to kind of get in there? Is it largely staffing-driven, still more, or just existing staff engagement through the caregiver app that you've rolled out?

Yeah, I mean, I think the way we look at it, you know, getting up into the mid-80% range, you know, we were probably, you know, low 80s kind of pre-COVID that dropped out into the 70s, and we've seen some rebound. But I think part of the push that we've made to kind of get into this range and where we'll continue to go is really kind of through the technology side. So think about, you know, our business, a lot of it is logistics based, right? So it's just scheduling efficiency, using our caregivers, making sure their availability matches up where we have clients and have authorized hours and needs. So the app that we've developed, that we've pushed out in now in Illinois, now in Texas, and to a certain extent in New Mexico, we've seen the benefits of that, where we can actually push out to caregivers the opportunity to take extra shifts, adjust their schedule, update their preferences to maximize the number We have a number of hours that they're working. And by and large, our caregivers want more hours, so it's helpful for them as well. And so we've seen in those instances, Illinois was first market that we rolled out the app. We saw that move up into that upper 80% range over a period of time. We rolled it out in Texas earlier this year. We've seen really nice response in our fill rate in Texas as a result. So I think the way we're looking at it is going to be primarily technology-based. I think some of the things we're doing in home care home base as well is we roll more and more states into that system. Some of the things that we built into that system from a scheduling perspective should help also with efficiency of scheduling. But I think our expectation would be, can we get the mid-80% range up into that upper 80% range over the next, you know, 12 to 18 months? We think that's probably a reasonable target for us.

Raj Kumar Analyst — Stevens

Got it. And then I guess on the staffing component, you know, just kind of with PCS and it being kind of non-skilled in nature, You're clearly hourly workforce. You're competing with kind of other nodes that are also kind of, you know, more mid-wage oriented. But as we kind of think about that, you know, with Medicaid work requirements, large or potentially seen as a tailwind, but you've caught out Montana. You're not really seeing any aggregate pickup in, say, work volumes from existing Medicaid patients who are required to kind of meet those eligibility standards. So how do we think about kind of staffing and ability to kind of continue that pace? And I know you guys had initiatives around turnaround in terms of onboarding to make it more efficient. But what inning would you say those initiatives are on as we kind of think about? You know, clue the demand side of the questions there, you know, kind of how does supply catch up to it?

Dirk Allison Chairman

Yeah, you know, I'd say we're probably in the mid-innings. We started this 18 months, two years ago, trying to make it easier for people to apply. Because if you think in terms of our caregiver, they work an average of 22 hours a week. A lot of them want more hours than that, so they may actually work for more than one agency at a time. Because the limitation we have is the overtime shift. So if we go into an overtime with an individual, we lose money on every hour above. So we have to be very careful. So they've learned to piecemeal that. So what it really means is when someone applies with us, we need to get them hours quickly. We need to get them to work because that's what they're looking on. And then we need to give them the ability to try to get as many hours as they want, as easily as they want without going into overtime, which is what the Addis Connect system is all about, is trying to do that. So for us, growth, that growth in hours is going to be key to who we can hire. When you're talking an industry like personal care, the industry itself probably averages 65% turnover. We average 50%. That's a lot of turnover. It's probably the best we've been in a long time, but we have to hire a lot of people to meet up with demand. And so, that's why we spent so much time on trying to make the, the... Applying and getting to the first hour of care convinced and easy. And so for us, we need that one-oh. Three or four to 110 hires per business day. We need to stay in that area right now at our size to be able to meet those needs. Some months you're going to be a little below that. You know, if you have a couple holidays in the month, people aren't looking for jobs at that time, you might drop a little bit. But on a quarterly basis, we've been pretty consistent in staying in that target. And that's really what our team focuses on is we have got to hire people. We got to figure out the reasons. If we're not getting them hired, why? And take care of that because our limitation to growth is not as much on the side of not having an elderly population to serve. It's more in most markets having the caregivers to serve, those in need. Yep.

Raj Kumar Analyst — Stevens

Got it. And then kind of the second driver volume census, you know, fluid's been a focus for investors as we kind of think about same-store census. I think Illinois and Texas are still kind of seeing, at least in the month of September, some softness relative to kind of earlier in the quarter. But you called out, you know, similar trends relative to the first half or third quarter. So, you know, maybe kind of as we think about, you know, there's some distinctions, you know, targeting higher hour clients or, yeah, and then, you know, maybe competitively, you know, because it seems like, you know, Illinois and Texas might also have providers that are similar or similarly scaled or, you know, partially scaled to an aspect that is there is there a competitive component to census that, you know, maybe. You know, that's kind of driving maybe new term weakness.

Dirk Allison Chairman

I think in Illinois over the last couple of years, because it is a market that has gone from being one people question the financial viability of the state, at least in our industry, to being one of the better states for the service that we operate. I think there have been some new folks come into the market, but most folks that are new come in the market. They're not competing with us on size. They're very small. Maybe they've got 10, 15, 20 patients, but those are 10 or 20 patients. We might have gotten before. So we have to do a job of making sure we're out in the community talking about getting these individual new folks on service. We also have started talking a little bit just so people understand. And Brian and I have tried to figure out what's the right way to talk about it. But, you know, our generally our standard patient. has 50 to 70 hours a month service. Those are the ones that really fit into your ability to take a caregiver and give them the hours they need. We haven't, in the past, we've had a number of clients under 10 hours a month that are really respite patients, and those are the ones we're not trying to move away from them, per se, but we're trying to make sure that we're getting the new clients that are It's easier for our caregivers to be able to get the hours they need, and that's where, you know, when we look at it, census itself doesn't tell us the story that I think some of the shareholders want to see, I think, but looking at that hourly census, the higher hour census, you definitely need to bring those on, and we need to continue to service some of the lower hour census where there's need, but focus more of our efforts on the other level, and that's what we've done. We're getting closer and closer to that annual tip over where we're actually showing positive census growth. So we will get there. The team is very focused on that. But all that being said, again, for us, while census is a key, we believe taking hours and driving to the authorized hour. We're not trying to actually go back to the state and say, you're giving us 70 hours, we need 80 hours. We're saying to them, you've given us 70 hours, and we're only working 56 of those hours. How do we get another four or five hours out of that appropriately to take care of that patient? And that's been our focus really the last, what, three years with Addis Connect.

Raj Kumar Analyst — Stevens

Got it. Maybe kind of framing, I guess, 4Q census trends in terms of, you know, you've given us kind of how October is done. Maybe as we kind of look at pre-COVID, before Medicaid re-termination and all those types of dynamics, like how have November and December, you know, trended from a census perspective pre-COVID as we kind of think about expectations for census for 4Q overall?

Dirk Allison Chairman

Now, the months of November and December, you're probably not going to grow census like you do other months, but year over year, they're the same. And the reason being, you've got Thanksgiving in November, you've got Christmas, and then really the start of New Year's in December. And realistically, that's where even the states themselves probably don't do. They're not a... They're not going out and getting authorized hours for new patients quite as quickly. So, the census should still grow. Our hope is to grow year over year. If you look each month during the fourth quarter, you're probably going to see November and December just be slightly lower only because of that aspect. It's not because the service is any less important. And for us as a team, though, you know, we've spent the last 11 years talking to our team about holidays, you still need to take care of the patient. And if they don't want you in your home on the holiday, can we work around the holiday? So existing patients are still very important, and that's what drives ours. It's the new patients that we don't control when the state approves of is that maybe we get in the holiday times we get, you know, a little less than what we would normally get in other quarters.

Raj Kumar Analyst — Stevens

Got it. Maybe just one last one on personal care before we move on. Clearly, managed care is a big component in terms of reimbursement. With New Mexico, the dollars are distributed by managed care organizations. And as we kind of think about that relationship and, you know, your ability to kind of scale these services and be the partner of choice, maybe just kind of walk us through some of the, you know, the rate dynamics and whether it's more explicitly linked to access to, you know, your caregiver supply or even fill rates and then whether, you know, they're more also intentionally looking at, say, hospitalization wastes, you know.

Yeah, I mean, I think particularly in New Mexico, where we, you know, we do have the opportunity to negotiate rates directly with the MCOs. I think the primary factor for them, and really kind of really a four-part thesis all along, has been really just more coverage and density. So if you're, you know, a large plant in New Mexico, you've got a big client base out there that needs services. I think they would prefer to work with, you know, firms like ourselves And I'm sure that you have a lot of resources that literally can cover wherever their constituents may live, not just in kind of pocketed areas. I think that's probably the first key. And then I think quality and performance is important to them as well. They want to make sure that we're, you know, adherence to the EVV mandates, we're actually providing the care. Our caregivers are showing up consistently. They don't have, you know, complaints from family members. That's important to them. I think it's less so kind of access to, you know, caregiver population and things like that. Like we're all out there recruiting at a very similar level. But I think those are probably the two primary components that they look to when they deal with us. And then I think, you know, additionally, you know, we deal a lot with those folks in New Mexico on the ground. But, you know, certain of the folks that deal in New Mexico also are national MCOs as well. And we have relationships at the national level. And I think that's helpful for us in kind of those conversations.

Raj Kumar Analyst — Stevens

You know, hospice has kind of, throughout the last couple years, has kind of been one of the strong suits, you know, high single-digit organic growth, you know, mainly, you know, recovering from the kind of pandemic era, you know, pull forward in moratoria. As we think about that business segment, how do you balance growth and margin? As we think about operating margins, I think they're slightly down year over year. I know there's been a rebuilding of the entire management team for that segment. Maybe just highlight the opportunities still available in hospice. And I know from an M&A perspective, it might still be a little too hot from a multiple perspective, but as we kind of think about even DeNovo's post-CMS's moratoria, how should we kind of think about the build-out of that segment?

Yeah, I mean, I think in hospice, you know, we consistently get, you know, 2% to 3% rate increase out of CMS. That's been pretty consistent the last several years. So, you know, we expect to see that continue. Nothing that we see today would indicate that there's going to be probably any real change there. I think our sales teams have done a really good job about they're really targeting the right referral sources, the right partners for us in that regard, and really growing just our ADC. We've seen nice, consistent growth in that area year over year, quarter over quarter. We sit here today. I think we talked about it recently. We're over 4,100 ADC, so we're a pretty sizable provider in that space. I think just on the margin profile, I mean, I think the key for us is in hospice is always going to be staffing efficiency is always going to be important on how many nurses do you have kind of per client, making sure you're being efficient in that regard. So that's something that we'll always kind of focus on. But I think we're pretty pleased with kind of the current trajectory of our hospice business. I think on the M&A side, you know, things have been very expensive the last few years. So we haven't done a deal. And pure ploy hospice, we've gotten a little bit of hospice and some other mixed assets over the last couple of years. It feels to us that maybe those multiples are starting to rationalize a little bit. I think if they come down into a range that would make more sense for us, I think those would be opportunities for us to maybe look at some things in that space.

Raj Kumar Analyst — Stevens

And maybe can you remind us kind of what you kind of look to target between small, medium, and large assets from a multiple perspective?

Yeah, I can talk more broadly just about all segments that we want. I think on the personal care side, in our view, small assets continue to be probably four to five times. They're a little more sizable. It could be upper single digits. Look at the two big deals we did, Gentiva and Accent Care, both probably very low, double-digit range, pre-synergy. I think on the home health side, and we think there could be more opportunities in that space next year with some of the stabilization and reimbursement. But we would look at, you know, typically home health, smaller side are going to be single digit multiples. You know, if it's more sizable, really good quality, could that start to press close to double digits? Yeah, that's probably fair. Hospice traditionally, pure play, decent size have been more mid-teen expectation, which are a little above probably what is comfortable for us. More recent deals we've seen have come down into what look like lower double-digit range, so there are opportunities there. That could make some sense for us. If there's smaller deals that maybe could slip into single digits, we would definitely be interested in those.

Raj Kumar Analyst — Stevens

I guess kind of thinking about hospice and kind of if we kind of think about if we're still in, you know, the, you know, late, maybe late innings of the recovery trend, or if the ballgame is kind of finished from that perspective, you know, admission is pretty stable, length stays above 100. I guess kind of, you know, is that kind of have we kind of reached kind of pre COVID levels? And then from a referral standpoint, always have we reached normalization between hospital and skilled nursing referral mix?

Yeah, I think for the most part, we're back into a definitely more stable environment. I wouldn't say it's probably necessarily quite back to pretty good, but I think we're very close. I think we've seen a lot of consistency in our business. I think our discharge length of stay, yeah, it's a little over 100. It's been kind of in that range pretty consistently, but I think that's pretty in line with what we see in the industry at large today. So it's a good spot for us to be. We focus more on kind of median length of stay. We've been kind of in that, you know, mid-20-day range. I think if we're there, maybe even upper 20 days, that's kind of a really a good place for us to operate and be, and we've been in that spot pretty consistently the last several quarters.

Raj Kumar Analyst — Stevens

Yeah, maybe just moving on to home health now, I guess, you know, inflection towards growth, kind of maybe looking at that path between both margins, you know, which have kind of, you know, have steadily risen as you kind of right size that business. But as you kind of think about now post 2026, how should we kind of think about the long term framing, you know, hospice, you know, mid to high single digits, home health, you know, it's kind of been in, you know, A standby mode in terms of getting the margin profile right before kind of looking for growth. And so how should we kind of think about that business on a go-forward basis?

Yeah, I think, you know, we're going to get, it looks like a 2.4% rate increase nationally that was put into place and finalized. First time we've seen a nice rate increase, obviously, in the last several years. So I think, you know, as long as that continues or is consistently kind of in that range, say, kind of like hospice 2% to 3%, we should get some volume growth. I think some of the changes we made in our home health division with leadership earlier this year, he made some changes in our sales teams and kind of our processes there as well that I think have started to pay some real dividends for us. So it was very nice for us to post even before this rate increase that's coming in 27, we were able to post a same store increase year over year, first time in probably several quarters for us. So, you know, all that being said, I think longer term, if all that continues, we would expect to be probably in the mid-single digits overall would be a fair expectation. It's still a small division for us. We're really going to elaborate in three kind of primary states. If we're able to expand and get some additional leverage in that business over time, maybe through M&A, maybe that can be helpful as well, but that's how I would look at it today.

Raj Kumar Analyst — Stevens

Got it. And as you kind of think about maybe episodic volumes versus kind of traditional MA per visit type of reimbursement structures, what are you guys on that front? Are you still working towards kind of having payers go towards episodic? Would it just be helpful in kind of that framing as we kind of think about your home health book today?

Yeah, our mix has been pretty consistent. We're a little more slanted toward episodic than per visit. I think our conversations with MA plans, we definitely would prefer episodic. You know, we've had a couple of wins in that regard. You know, some folks, you know, want to still stick to the per visit. We've gotten some better rates there. But I think we've been pretty specific about who we'll work with, what the structure is, what profitability looks like when we're really thinking about, you know, which cases we're going to take, where we'll put our resources. And I think we've gotten into a pretty good rhythm. But we really haven't seen, to be honest, a couple of years ago, the industry at large saw a pretty big shift right in that regard into MA. It's been pretty stable for us for, I'd say, the last, you know, probably year, year and a half.

Raj Kumar Analyst — Stevens

As we kind of come up on time, maybe just to kind of close out, I guess when kind of investors, you know, maybe debate the added story, you know, there's... You know, parts of, you know, thinking about Medicaid rate durability, especially with the one big, beautiful bill, caregiver availability, which kind of unlocks that demand part of the equation. Yeah, just maybe also the kind of differentiated platform and how that ultimately, you know, works together. I guess, what do you kind of believe is the most underappreciated aspect of the kind of potential earnings power of this business, say, over the next three to five years?

Dirk Allison Chairman

I think one of the things is the ability to use technology in a bridge program. We've demonstrated it on 20% of our business, but we got this very large and nice PCS business that we are starting to develop a lot of data on these individuals and the potential of needs down the road that we could serve. I think getting the home care home base transaction done, which we should be converted, our plan is to be totally converted by the end of 27, with the exception of now we've got Accent Care coming on, which we'll follow after that, but through Texas, which would, the first part of Texas, which would be the Gentifa transaction, hopefully by the end of 27. So now all of a sudden, you're going to have all this technology and information that you're going to be able to mine data to figure out how do we continue to offer the right services to those folks up the line, whether it be, you know, even in hospice, you can service them with PCS. And so I think that's one of the real aspects out there. And then the other one, which is people do know about, but it's as we continue to drive. Our Addis Connect, throughout the company, moving our authorized hours served up into that high 80s is going to have real impact on our bottom line. So those are the two things we're really focused on over the next 24 to 36 months of getting them done and hopefully seeing the benefits of those.

Raj Kumar Analyst — Stevens

All right, perfect. Well, I appreciate you guys being here. Great conversation. Thanks, Ross.

Dirk Allison Chairman

Appreciate it. Appreciate it.

Analyst Q&A · 1 question
Full-screen source Call document